Clinical Trial Update: Evaluation of the Safety and Efficacy of Hemophilia A Gene Therapy Drugs [Phase 2, Phase 3]

View source ↗

Summary

Ongoing Phase 2/Phase 3 clinical trials are evaluating the safety and efficacy of a gene therapy for Hemophilia A, sponsored by Shanghai Xinzhi BioMed Co., Ltd.…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• Hemophilia A gene therapy

Snippet

Sponsor: Shanghai Xinzhi BioMed Co., Ltd. | Conditions: Hemophilia A | Phase 2, Phase 3 | Status: RECRUITING